Serum insulin-like growth factor-I and binding proteins (IGF BP-1 and IGF BP-3) concentrations after renal transplantation in adults. 1996

F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
Department of Clinical Chemistry, Nancy Medical School, Central Hospital, France.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
May 2009, The Journal of clinical endocrinology and metabolism,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
October 2012, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
August 1999, Journal of Korean medical science,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
August 1992, The Journal of clinical endocrinology and metabolism,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
December 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
September 1993, The Journal of endocrinology,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
December 2007, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
September 1990, Endocrinology,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
May 2012, Il Giornale di chirurgia,
F Hussenet, and B Dousset, and P Gervais, and J Capiaumont, and A Schuhmacher, and P Nabet, and M Kessler
January 1999, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!